A Juno and Celgene collaboration will focus on T cell therapeutics for cancer, one in eight people is pre-diabetic but a new study shows a willingness to change behavior if made aware of their risk.
Neil Versel | 3:30 pm, July 2
Meghana Keshavan | 2:47 pm, July 2
Chris Seper | 9:46 am, July 1
Enough talk about patient engagement. Take your insights and mold them into a mandate. Attendees of MedCity ENGAGE on July 14-15 in Bethesda will do just that. Teams will work on three issues critical to patient engagement – led by healthcare organizations already dedicated to the issue: Kindred Healthcare, Sharecare and Lumiata. Each group will present their ideas to the full MedCity ENGAGE audience. The audience will vote, and MedCityNews.com will publish the winning idea.